All In Biotech

Drug Trial Radar · NCT03760562

The Risk of Hypertension Associated With Oral Glucocorticoids in Chronic Inflammatory Diseases

The Risk of Hypertension Associated With Oral Glucocorticoids in Chronic Inflammatory Diseases in England.

Last checked: Nov 19, 2026Latest source record: Nov 30, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

111,804

Actual

Start

Jan 1, 1998

Primary completion

Jan 30, 2015

Study completion Sep 30, 2015

Sponsor

Lead sponsor
University of LeedsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 30, 2018

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

Glucocorticoids are widely used for the treatment of chronic inflammatory diseases. In 2008, it was estimated that 0.8% of the United Kingdom adult population had used long-term (≥ 3 months) glucocorticoids, rising to 3% in women aged over 80 years. The aim of the project is to investigate the dose-response estimates of risk of high blood pressure associated with oral glucocorticoids.

Conditions

  • Hypertension

Interventions

  • GlucocorticoidsDrug

    Oral Glucocorticoids.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Glucocorticoid-related hypertensionTime frame: 18 years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.